Clinical Trial Update: Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating epirubicin in women undergoing surgery for Stage I-III breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Epirubicin (epirubicin)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED